(Conferences, symposia and invited talks)
Speaker and participant: ‘Brave New Brains: The future of brain-computer interfaces’, State Library, Melbourne, 27th August 2018.
Keynote Speaker: Maslen, H. ‘Thinking Aloud: The development and ethics of neural speech prostheses’, Neuroscience and Society 2018, Sydney, Australia, 23th-25th August 2018.
Maslen, H. ‘AI, Predictive Policing and Preparatory Offences’, 2018 Uehiro-Carnegie-Oxford Conference on “Ethics and the Future of Artificial Intelligence”, Carneigie Council, New York, May 16-18, 2018
National Institute of Health (US), invited panellist: ‘Neurointerventions and challenges in informed consent’, National Institute of Health, Bethesda, MD, United States, 26th October, 2017.
European parliament keynote address: Maslen, H. ‘Ethics of AMR Policy: Antibiotics in Farming’, “Scientific, Human Health, Husbandry, And Socio-Economic Aspects Of Antibacterial Resistance: Time To Act”, European Parliament, Brussels, 28th June 2017.
Maslen, H. ‘Neuroprostheitics for Speech: Philosophical and Ethical Questions’, Neuroethics Network Annual Meeting, Paris, 19th-22nd June, 2017.
Maslen, H. & Pugh, J. ‘Drugs That Make You Feel Bad’? Remorse-Based Mitigation and Neurointerventions’, “Neurointerventions & Crime Symposium”, University of Swansea, 3rd-4th April 2017
Maslen, H. ‘Motivational enhancement and praiseworthiness for achievement’, “Meet Tomorrow’s World: Ethics of Emerging Technologies for the Science of Learning”, University of California San Diego (UCSD), 11th November 2016.
Maslen, H. ‘How polite must I be to cold-callers?’, HowTo Academy Public Event, The Tabernacle, London, 28th October 2016.
Maslen, H. ‘The Case of Consumer Non-Invasive Neuromodulation: Integrating ELSA/ RRI into Research, Development, and Regulation’, OECD Workshop “Neurotechnology and Society: Strengthening Responsible Innovation in Brain Science” 15th-16th September 2016, Washington D.C.
Maslen, H. ‘Brain stimulation for treatment and enhancement in children: trade-offs, open futures, and ethical limits to parental proxy decision-making’, Public Lecture, University of Tokyo Centre for Philosophy, 24th August 2016.
Maslen, H. ‘Regulating Enhancement Devices: The Contribution of Bioethics’, “The International Association of Bioethics (IAB) World Congress’, Edinburgh, 14th-17th June, 2016.
Maslen, H. ‘DBS for the treatment of anorexia nervosa and chronic pain’, “NEURON Era-Net workshop”, University of Milan, Milan, 9th May, 2016.
Maslen, H. ‘Ethical coercion: When can we limit freedom in the face of pandemics?’, “The un-ending challenges of infectious disease, policy and practice”, Kyung Hee University, Seoul, 29th-30th April 2016. (With acknowledgements to A. Giubilini, T. Douglas and J. Savulescu.)
Keynote Speaker: Maslen, H. ‘Brain stimulation for treatment and enhancement in children: trade-offs, open futures, and ethical limits to parental proxy decision-making’, An International Symposium: “The Ethical Use of Emerging Technologies”, University of Queensland, Brisbane, 20th-21st March 2016
Maslen, H. ‘Deep Brain Stimulation for Anorexia Nervosa and Chronic Pain’, Australian Centre for Health Law Research Event, Queensland University of Technology, Brisbane, 17th March 2016
Maslen,H. and Reinikainan, M. ‘TOPRA Webinar: brain stimulation, including the aspects relating to its inclusion in Annex XV of the new regulation on medical devices’, presented to The Organisation for Professionals in Regulatory Affairs (TORPA), London, 8th March 2016
Maslen, H. ‘The Ethics of Deep Brain Stimulation for Chronic Pain’, Oxford-Duke Workshop in Practical Ethics, “Medicine, Society and Value”, Duke University, NC, 25th-2gth February, 2016
Maslen, H. ‘Retributive Mercy and Remorse’, LSE Seminar Series on “Criminal Law and Justice Theory”, London School of Economics, 18th February, 2016
Public Seminar: ‘Mind machines – the promise and problems of cognitive enhancement devices‘, with Roi Cohen Kadosh, Oxford Martin School Seminar Series, “Technology for tomorrow – The research shaping our future”, 4th February, 2016
Invited panellist: ‘Justice, equity, and unintended consequences: noninvasive technologies’, “American Academy Human Performance Enhancement Workshop”, American Academy of Arts and Sciences, Boston, 21st-22nd January, 2016
Maslen, H. ‘Deep brain stimulation for the treatment of chronic pain: wellbeing and risking death’, Guest Seminar at the Center for Bioethics at Harvard Medical School, Harvard University, 19th January, 2016
Keynote speaker: ‘Scientific description, philosophical prescription, and the realities of law: Interdisciplinary approaches to the regulation of human enhancement technologies’, Conference on “Human Enhancement and the Law: Regulating for the Future”, University of Oxford, UK, 7th-8th January, 2016
Invited panellist: ‘Implementing Gray Matters: Perspectives on Bioethics Commission Recommendations’, International Neuroethics Society Annual Meeting, Chicago, 16th October, 2015
Maslen, H. ‘Brain stimulation for pediatric treatment versus enhancement: Implications for the moral permissibility of interventions in children’, presented at “8th International Conference of Ethics in Biology, Engineering and Medicine”, SUNY Downstate Medical Centre, New York, 24th – 26th April, 2015
Invited by the Institute of Medicine of the National Academies to speak on ‘Neuromodulation and Unsupervised Use’ at “Non-Invasive Neuromodulation of the Central Nervous System: A Workshop”, National Institutes of Health, Washington DC, 2nd – 3rd March 2015
Invited speaker: ‘The Ethics of Cognitive Enhancement: What Role Should Neuroscience Play?’, “Second Annual Neuroscience Symposium”, Kings College London, 20th February 2015
Maslen H. ‘Are all enhancements equal? Examining the merit of distinguishing between enhancement effects in the cheating debate’, presented at the “Cognitive Enhancement – Moral, Legal and Scientific Challenges Conference”, Delft, Netherlands, 13th-15th August 2014
Faulmüller, N., Crusius, J., Heise, F., Caviola, L., Maslen, H., & Hewstone, M. ‘You pop pills, I suffer side-effects? Empirical evidence for indirect psychological costs of cognitive enhancement’. Presented at the “Cognitive Enhancement: Moral, Legal and Scientific Challenges Conference”, Delft, Netherlands, 13th-15th August 2014
Goold, I., & Maslen, H. ‘Must the Surgeon Take the Pill? Negligence Duty in the Context of Cognitive Enhancement’, panel session at the “Society for Applied Philosophy Annual Conference”, Oxford, 29th June 2014
Keynote speaker: ‘Moral Artificial Intelligence: Moral AI?’, “HUMASCEND 2013: International Workshop on Human-Machine Systems, Cyborgs and Enhancing Devices”, Manchester, 13th October 2013
Invited Panellist debating ‘Will robots and enhanced humans steal our jobs?’ at the “The Work Foundation 2013 Annual Debate”, London, 11th June 2013
Maslen, H. ‘Altruism, Neurointerventions and Enhancing Morality’, invited to present at the “International Conference on Enhancement: Cognitive, Moral and Mood”, Centre for the Study of Bioethics and The Oxford Centre for Neuroethics, Belgrade, 14th -16th May 2013
Goold, I. & Maslen H. ‘Must The Surgeon Take the Pill? Negligence Duty in the Context of Cognitive Enhancement’, invited to present at the “Workshop on Neurointerventions and the Law”, University of Hamburg, 7th-8th March 2013
Maslen, H. ‘From Opportunity to Obligation: Ethical and Legal Dimensions of Requiring Enhancement’, invited as one of the three speakers to speak at the “Human Sciences Symposium: Beyond Human”, University of Oxford, 9th February 2013
Vincent, N., Santoni de Sio, F., Maslen, H., & Faulmüller, N. ‘Enhancing Responsibility’, presented at the “2nd Workshop on Neuroenhancement and Ethics”, University of Bochum, 1st-2nd February 2013
Maslen, H. & Goold, I. ‘Cognitive Enhancement: Implications for Legal Responsibility’, presented at the AHRC-funded workshop: “Moral and Criminal Responsibility and Neuroscience”, University of London, 18th-19th June 2012
Maslen, H. & Goold, I. ‘Cognitive Enhancement: A Perspective from Medical Law and Ethics’, presented at the “21st Century Body Symposium”, University College London, 18th May 2012